Treating cancer with amplitude-modulated electromagnetic fields: a potential paradigm shift, again?

2012 · Benefit · Low evidence

← Research stream

BenefitLow evidencePaper 6742

Study snapshot

Publicationmanual · 2012

Study typeother

Reported directionBenefit

Evidence ratingLow

Abstract

Editorial Open access Published: 17 January 2012 The Zimmerman et al (2012) study published here, coupled with the group's two preceding papers (Barbault et al, 2009; Costa et al, 2011), identify a potential modality for treating tumours at a dramatic reduction in trauma and cost. This set of clinical and explanatory laboratory results should be understood in the context of the history of research into the biological effects of electromagnetic fields (EMFs). The most successful clinical application is the use of EMF to initiate fusion in fractured long bones that would not otherwise heal. Pulsed fields were designed to simulate the natural piezoelectric signals generated from bones under varying stress while walking (e.g., Bassett, 1985). There are also other reports that EMF can reduce pain and stimulate wound healing after surgery. The group's two previous clinical reports were critical to the design of this new Zimmerman et al study. Barbault et al (2009) described how they obtained the specific frequencies for different tumour diagnoses, which are then used in the amplitude-modulated (AM)-EMF treatment of those patients to stabilise the disease beyond normal expectations. Costa et al (2011) reported surprising clinical benefits from using the specific AM-EMF signals to treat advanced hepatocellular carcinoma, stabilising the disease and even producing partial responses up to 58 months in a subset of the patients. Now Zimmerman et al have examined the growth rate of human tumour cell lines from liver and breast cancers along with normal cells from those tissues exposed to AM-EMF. Reduced growth rate was observed for tumour cells exposed to tissue-specific AM-EMF, but no change in growth rate in normal cells derived from the same tissue type, or in tumour or normal cells from the other tissue type. The growth rate inhibitory response was field-strength (SAR) and exposure-time dependent. In ancillary tests, they observed reduction in gene expression and increases in mitotic spindle dysfunction only for the AM-EMF exposure that reduced the cell growth rate. The work of Zimmerman et al, Costa et al and Barbault et al was not done in a vacuum. More than 30 years ago, Suzanne Bawin working in Ross Adey's lab (Bawin et al, 1975), with independent replication by my group (Blackman et al, 1979), demonstrated that biological effects could be caused by certain AM frequencies on a carrier wave but not other frequencies, similar to the current work. Subsequent reports in the 1980s by several groups continued to support and extend the initial findings (Adey, 1992; Blackman, 1992). This growing collection of reports demonstrating AM-EMF-induced biological effects led to recognition by national and international authorities that this modality needed to be considered in hazard evaluation, in addition to field-induced heating as a cause for health concern. The National Council on Radiation Protection and Measurements (1986) recommended a reduction in the allowable exposure intensity limits for AM radiation above a certain level, and the World Health Organization (1993) explicitly acknowledged AM as a future issue to be examined in setting exposure guidelines. Unexpectedly, research funding for this area dried up around 1990 and scientific advances dramatically slowed. A promising area of research fell by the wayside. The Zimmerman et al paper, providing essential laboratory data to support the two previous clinical treatment papers, has resurrected the promising AM-EMF paradigm. It should lead to a major reevaluation of this novel and potentially effective treatment for cancer and possibly other conditions. This study demonstrates the fundamental requirement for a biological ‘information content’ code (i.e., the AM spectral profile, much like different AM radio stations with different content – e.g., all news, or music) that can affect tumour cells from the tissue of origin, while apparently being ignored by normal cells from various tissues and tumour cells from different tissues of origin. The correspondence between AM-EMF-induced effects on cell proliferation, gene expression, and mitotic spindle dysfunction provide some clues to a possible biological mechanism of action. The tools developed in Barbault et al (2009) to identify relevant treatment frequencies can be seen to have direct clinical and medical relevance in determining the characteristics of a new modality that may prove useful in cancer treatment. The precision of the frequency definitions, down to 1 mHz, is very unusual, but it is reminiscent of the biological effects reported for 40–48-GHz frequencies by Grundler et al (1982), and may

Machine Enhanced Logic

AI evidence extraction

Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.

Study typeother

Effect directionbenefit

Populationpatients with tumors, human tumor cell lines from liver and breast cancers

Sample sizeNot supplied

ExposureNot supplied

Evidence strengthLowConfidence: 30% · Peer reviewed: yes

Main findings

Amplitude-modulated electromagnetic fields (AM-EMF) exposure reduced growth rate of tumor cells from tissue-specific origins without affecting normal cells, with effects dependent on field strength and exposure time. Clinical reports indicated disease stabilization and partial responses in cancer patients treated with specific AM-EMF frequencies. The study suggests a biological mechanism involving gene expression changes and mitotic spindle dysfunction.

Outcomes measured

tumor cell growth rate
gene expression
mitotic spindle dysfunction
disease stabilization
partial tumor response

Limitations

No randomized controlled trials reported
Sample sizes and detailed methodology not provided in abstract
Mechanism of action not fully elucidated
Potential publication bias as editorial summarizes prior studies

View raw extracted JSON

{
  "study_type": "other",
  "exposure": {
    "band": null,
    "source": null,
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "patients with tumors, human tumor cell lines from liver and breast cancers",
  "sample_size": null,
  "outcomes": [
    "tumor cell growth rate",
    "gene expression",
    "mitotic spindle dysfunction",
    "disease stabilization",
    "partial tumor response"
  ],
  "main_findings": "Amplitude-modulated electromagnetic fields (AM-EMF) exposure reduced growth rate of tumor cells from tissue-specific origins without affecting normal cells, with effects dependent on field strength and exposure time. Clinical reports indicated disease stabilization and partial responses in cancer patients treated with specific AM-EMF frequencies. The study suggests a biological mechanism involving gene expression changes and mitotic spindle dysfunction.",
  "effect_direction": "benefit",
  "limitations": [
    "No randomized controlled trials reported",
    "Sample sizes and detailed methodology not provided in abstract",
    "Mechanism of action not fully elucidated",
    "Potential publication bias as editorial summarizes prior studies"
  ],
  "evidence_strength": "low",
  "confidence": 0.3,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "amplitude-modulated electromagnetic fields",
    "cancer treatment",
    "tumor cell growth",
    "gene expression",
    "mitotic spindle dysfunction",
    "hepatocellular carcinoma"
  ],
  "suggested_hubs": [
    {
      "slug": "emf-cancer-treatment",
      "weight": 0.9,
      "reason": "Focus on treating cancer with amplitude-modulated EMF signals."
    }
  ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.

Identifiers and source

DOI: Not supplied
PubMed: Not supplied

Read the original paper →

Related papers

← Back to the Research Library